EastPharma Ltd. reported revenue results for the first quarter ended March 31, 2017. According to IFRS results, revenue in the first quarter 2017 was USD 58.6 million, down 8.0% over USD 63.7 million from the same period in 2016. In Turkish Lira terms, revenue increased by 15.5% in the same period (net sales in the first quarter of 2017 were TRY 216.4 million against TRY 187.4 million net sales in the first quarter of 2016). The company's sales decrease in US dollar terms was mainly due to depreciation of Turkish Lira against hard currencies.